TheraCryf appoints Australian partner for addiction treatment trial
Biotech company TheraCryf has appointed Avance Clinical to support regulatory preparations for its first human trial of an addiction treatment.
The Australian contract research organisation will support TheraCryf's application to a Human Research Ethics Committee and the subsequent Clinical Trial Notification to Australia's Therapeutic Goods Administration.
Avance Clinical was selected following a competitive process.
TheraCryf expects to complete the remaining clinic-enabling documentation in the fourth quarter of 2026 and c... You can carry on reading TheBusinessDesk.com for free, but you have reached the maximum number of pages an unregistered user can view. To register for an account, click here or login below...
